Amdocs DOX Q1 2026 Earnings Slim EPS Miss Masks Steady Operational Performance MBX Q1 2026 Earnings Narrower Than Expected Loss as Clinical Progress Continues BLDR Q1 2026 Earnings EPS Misses Estimates by 284 Stock Edges Higher Catalyst Pharmaceuticals CPRX Q1 2026 Earnings EPS Beat Signals Operational Strength Amid Quiet Revenue Reporting VSNT Q1 2026 Earnings EPS Beats Estimates Amid Quiet Revenue Disclosure Japan Raises Residency Visa Fee Cap to 630 Potentially Affecting Foreign Workers and Employers CLVT Q1 2026 Earnings EPS Surprises 219 Above Estimates Despite Stock Decline Anthropic Surpasses OpenAI as Most Valuable AI Startup After 65 Billion Funding Round